BANK OF AMERICA CORP /DE/ - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 121 filers reported holding CARIBOU BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$11,026,494
-5.7%
2,306,798
-16.2%
0.00%0.0%
Q2 2023$11,693,832
-16.3%
2,751,490
+4.5%
0.00%0.0%
Q1 2023$13,977,965
+20.7%
2,632,385
+42.8%
0.00%0.0%
Q4 2022$11,579,704
+525.6%
1,843,902
+950.6%
0.00%
Q3 2022$1,851,000
+366.2%
175,507
+139.9%
0.00%
Q2 2022$397,000
+120.6%
73,146
+273.7%
0.00%
Q1 2022$180,000
-86.8%
19,576
-78.3%
0.00%
Q4 2021$1,360,000
+65.7%
90,142
+162.2%
0.00%
Q3 2021$821,00034,3750.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 474,067$2,266,04015.18%
Elmwood Wealth Management, Inc. 2,364,415$11,301,9045.45%
PFM Health Sciences, LP 6,724,715$32,144,1381.51%
SILVERARC CAPITAL MANAGEMENT, LLC 892,786$4,267,5171.29%
Avidity Partners Management LP 6,050,212$28,920,0131.16%
Paradigm Biocapital Advisors LP 2,944,513$14,074,7720.96%
Kynam Capital Management, LP 1,068,527$5,107,5590.84%
Green Alpha Advisors, LLC 110,524$528,3050.41%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,500,000$16,730,0000.37%
Bruce & Co., Inc. 200,000$956,0000.33%
View complete list of CARIBOU BIOSCIENCES INC shareholders